BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Douglas Miehm does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ONCYOncolytics Biotech Inc | Buy | $5.00 | Mar 2025 | +59.8% | Miss |
 LGNDLigand Pharmaceuticals Incorporated | Buy | $143.00 | Dec 2024 | +50.5% | Hit |
| LGNDLigand Pharmaceuticals Incorporated | Buy | $140.00 | Nov 2024 | +62.5% | Hit |
 AUPHAurinia Pharmaceuticals Inc | Buy | $8.00 | Feb 2024 | +41.8% | Hit |
 BLCOBausch + Lomb Corp | Buy | $21.00 | Jul 2023 | −25.2% | Miss |
| BLCOBausch + Lomb Corp | Buy | $20.00 | May 2023 | −29.4% | Hit |
| AUPHAurinia Pharmaceuticals Inc | Buy | $11.00 | Feb 2023 | −44.3% | Hit |
| BLCOBausch + Lomb Corp | Buy | $20.00 | Feb 2023 | −21.0% | Hit |
| BLCOBausch + Lomb Corp | Buy | $20.00 | Feb 2023 | −36.5% | Hit |
| AUPHAurinia Pharmaceuticals Inc | Buy | $11.00 | Jan 2023 | +13.8% | Hit |
| AUPHAurinia Pharmaceuticals Inc | Buy | $10.00 | Nov 2022 | +65.6% | Hit |
 BHCBausch Health Companies Inc | Buy | $12.00 | Jul 2022 | +4.4% | Miss |
| BHCBausch Health Companies Inc | Buy | $17.00 | May 2022 | −47.5% | Miss |
| BHCBausch Health Companies Inc | Buy | $21.00 | May 2022 | −43.7% | Miss |
| AUPHAurinia Pharmaceuticals Inc | Buy | $22.00 | Apr 2022 | +5.2% | Miss |
| AUPHAurinia Pharmaceuticals Inc | Buy | $27.00 | Mar 2022 | −20.9% | Miss |
| AUPHAurinia Pharmaceuticals Inc | Buy | $31.00 | Feb 2022 | −51.5% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.